A Functional Screen in Human Cells Identifies UBF2 As an RNA Polymerase II Transcription Factor That Enhances the Beta-catenin Signaling Pathway

Overview

Journal Mol Cell Biol

Specialty Cell Biology

Date 2003 May 16

PMID 12748295

Citations 12

Authors

Dorre A Grueneberg

Lourdes Pablo

Kang-Quan Hu

Paul August

Zhigang Weng

Jacqueline Papkoff

Affiliations

Soon will be listed here.

Abstract

beta-Catenin signaling plays an important role in the development of many organisms and has a key part in driving the malignant transformation of epithelial cells comprising a variety of cancers. beta-Catenin can activate gene expression through its association with transcription factors of the lymphoid enhancer factor 1 (LEF-1)/T-cell factor (TCF) family. We designed a screen in human cells to identify novel genes that activate a beta-catenin-LEF/TCF-responsive promoter and isolated the high-mobility group box transcription factor, UBF2. UBF1 and UBF2 are splice variants of a common precursor RNA. Although UBF1 has been shown to activate RNA polymerase I-regulated genes, the function of UBF2 has remained obscure. Here, we show for the first time that both UBF1 and UBF2 activate RNA polymerase II-regulated promoters. UBF2 associates with LEF-1, as shown by coimmunoprecipitation experiments, and potentiates transcriptional activation stimulated by LEF-1/beta-catenin from a synthetic promoter with multimerized LEF/TCF binding sites and a natural cyclin D1 promoter with consensus LEF/TCF binding sites. Downregulation of endogenous UBF expression using an RNA interference approach reduces transcriptional activation of a beta-catenin-LEF/TCF-responsive promoter by means of overexpressed beta-catenin, further implicating UBF as a transcriptional enhancer of the beta-catenin pathway.

Citing Articles

Behavioral and molecular effects of Ubtf knockout and knockdown in mice.

Hori R, Khan M, Xiao J, Hargrove P, Moss T, Ledoux M Brain Res. 2022; 1793:148053.

PMID: 35973608 PMC: 10908547. DOI: 10.1016/j.brainres.2022.148053.

Super-resolution in situ analysis of active ribosomal DNA chromatin organization in the nucleolus.

Maiser A, Dillinger S, Langst G, Schermelleh L, Leonhardt H, Nemeth A Sci Rep. 2020; 10(1):7462.

PMID: 32366902 PMC: 7198602. DOI: 10.1038/s41598-020-64589-x.

The linker histone H1.2 is a novel component of the nucleolar organizer regions.

Chen J, Teo B, Cai Y, Wee S, Lu J J Biol Chem. 2018; 293(7):2358-2369.

PMID: 29301938 PMC: 5818188. DOI: 10.1074/jbc.M117.810184.

A recurrent de novo missense mutation in UBTF causes developmental neuroregression.

Toro C, Hori R, Malicdan M, Tifft C, Goldstein A, Gahl W Hum Mol Genet. 2018; 27(4):691-705.

PMID: 29300972 PMC: 5886272. DOI: 10.1093/hmg/ddx435.

Transcription factors that influence RNA polymerases I and II: To what extent is mechanism of action conserved?.

Zhang Y, Najmi S, Schneider D Biochim Biophys Acta Gene Regul Mech. 2016; 1860(2):246-255.

PMID: 27989933 PMC: 5280279. DOI: 10.1016/j.bbagrm.2016.10.010.

References

Mayall T, Sheridan P, Montminy M, Jones K . Distinct roles for P-CREB and LEF-1 in TCR alpha enhancer assembly and activation on chromatin templates in vitro. Genes Dev. 1997; 11(7):887-99. DOI: 10.1101/gad.11.7.887. View

Orford K, Orford C, Byers S . Exogenous expression of beta-catenin regulates contact inhibition, anchorage-independent growth, anoikis, and radiation-induced cell cycle arrest. J Cell Biol. 1999; 146(4):855-68. PMC: 2156133. DOI: 10.1083/jcb.146.4.855. View

Hecht A, Vleminckx K, Stemmler M, VAN Roy F, Kemler R . The p300/CBP acetyltransferases function as transcriptional coactivators of beta-catenin in vertebrates. EMBO J. 2000; 19(8):1839-50. PMC: 302022. DOI: 10.1093/emboj/19.8.1839. View

Brabletz T, Jung A, Dag S, Hlubek F, Kirchner T . beta-catenin regulates the expression of the matrix metalloproteinase-7 in human colorectal cancer. Am J Pathol. 1999; 155(4):1033-8. PMC: 1867011. DOI: 10.1016/s0002-9440(10)65204-2. View

Voit R, Schnapp A, Kuhn A, Rosenbauer H, Hirschmann P, Stunnenberg H . The nucleolar transcription factor mUBF is phosphorylated by casein kinase II in the C-terminal hyperacidic tail which is essential for transactivation. EMBO J. 1992; 11(6):2211-8. PMC: 556688. DOI: 10.1002/j.1460-2075.1992.tb05280.x. View

OMahony D, Xie W, Smith S, Singer H, Rothblum L . Differential phosphorylation and localization of the transcription factor UBF in vivo in response to serum deprivation. In vitro dephosphorylation of UBF reduces its transactivation properties. J Biol Chem. 1992; 267(1):35-8. View

Satoh S, Daigo Y, Furukawa Y, Kato T, Miwa N, Nishiwaki T . AXIN1 mutations in hepatocellular carcinomas, and growth suppression in cancer cells by virus-mediated transfer of AXIN1. Nat Genet. 2000; 24(3):245-50. DOI: 10.1038/73448. View

Bell S, Learned R, Jantzen H, Tjian R . Functional cooperativity between transcription factors UBF1 and SL1 mediates human ribosomal RNA synthesis. Science. 1988; 241(4870):1192-7. DOI: 10.1126/science.3413483. View

Collins R, Treisman J . Osa-containing Brahma chromatin remodeling complexes are required for the repression of wingless target genes. Genes Dev. 2000; 14(24):3140-52. PMC: 317146. DOI: 10.1101/gad.854300. View

10.

Copenhaver G, Putnam C, Denton M, Pikaard C . The RNA polymerase I transcription factor UBF is a sequence-tolerant HMG-box protein that can recognize structured nucleic acids. Nucleic Acids Res. 1994; 22(13):2651-7. PMC: 308223. DOI: 10.1093/nar/22.13.2651. View

11.

Roose J, Clevers H . TCF transcription factors: molecular switches in carcinogenesis. Biochim Biophys Acta. 1999; 1424(2-3):M23-37. DOI: 10.1016/s0304-419x(99)00026-8. View

12.

Rivera V, Clackson T, Natesan S, Pollock R, Amara J, Keenan T . A humanized system for pharmacologic control of gene expression. Nat Med. 1996; 2(9):1028-32. DOI: 10.1038/nm0996-1028. View

13.

MUNEMITSU S, Albert I, Rubinfeld B, Polakis P . Deletion of an amino-terminal sequence beta-catenin in vivo and promotes hyperphosporylation of the adenomatous polyposis coli tumor suppressor protein. Mol Cell Biol. 1996; 16(8):4088-94. PMC: 231405. DOI: 10.1128/MCB.16.8.4088. View

14.

Molenaar M, van de Wetering M, Oosterwegel M, Peterson-Maduro J, Godsave S, Korinek V . XTcf-3 transcription factor mediates beta-catenin-induced axis formation in Xenopus embryos. Cell. 1996; 86(3):391-9. DOI: 10.1016/s0092-8674(00)80112-9. View

15.

Putnam C, Copenhaver G, Denton M, Pikaard C . The RNA polymerase I transactivator upstream binding factor requires its dimerization domain and high-mobility-group (HMG) box 1 to bend, wrap, and positively supercoil enhancer DNA. Mol Cell Biol. 1994; 14(10):6476-88. PMC: 359177. DOI: 10.1128/mcb.14.10.6476-6488.1994. View

16.

Tanaka M, Herr W . Differential transcriptional activation by Oct-1 and Oct-2: interdependent activation domains induce Oct-2 phosphorylation. Cell. 1990; 60(3):375-86. DOI: 10.1016/0092-8674(90)90589-7. View

17.

Bruhn L, Munnerlyn A, Grosschedl R . ALY, a context-dependent coactivator of LEF-1 and AML-1, is required for TCRalpha enhancer function. Genes Dev. 1997; 11(5):640-53. DOI: 10.1101/gad.11.5.640. View

18.

McStay B, Hu C, Pikaard C, Reeder R . xUBF and Rib 1 are both required for formation of a stable polymerase I promoter complex in X. laevis. EMBO J. 1991; 10(8):2297-303. PMC: 452920. DOI: 10.1002/j.1460-2075.1991.tb07766.x. View

19.

Tejpar S, Li C, Yu C, Poon R, Denys H, Sciot R . Tcf-3 expression and beta-catenin mediated transcriptional activation in aggressive fibromatosis (desmoid tumour). Br J Cancer. 2001; 85(1):98-101. PMC: 2363921. DOI: 10.1054/bjoc.2001.1857. View

20.

Imai H, Fritzler M, Neri R, Bombardieri S, Tan E, Chan E . Immunocytochemical characterization of human NOR-90 (upstream binding factor) and associated antigens reactive with autoimmune sera. Two MR forms of NOR-90/hUBF autoantigens. Mol Biol Rep. 1994; 19(2):115-24. DOI: 10.1007/BF00997157. View